<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16534">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01783509</url>
  </required_header>
  <id_info>
    <org_study_id>LGMD Nat Hx</org_study_id>
    <nct_id>NCT01783509</nct_id>
  </id_info>
  <brief_title>Limb Girdle Muscular Dystrophy (LGMD) Natural History</brief_title>
  <official_title>Longitudinal Assessment and Genetic Understanding of Limb-Girdle Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susan Sparks</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muscular Dystrophy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Carolinas Healthcare System</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand more about limb-girdle muscular dystrophy.
      Therefore, the investigators would like to track the following information collected once a
      year from patients with GENETICALLY CONFIRMED LGMD:  quality of life questionnaires, muscle
      strength, motor function, routine examination, assessment of  patient (or parent)
      understanding of LGMD, and serum (blood) for growth factors, cytokines, and biomarkers (all
      parts of your blood).  By tracking this information, we hope to be able to understand more
      about the diagnosis, progression and natural history of this disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Comprehensive clinical evaluation of individuals with GENETICALLY CONFIRMED LGMD, according to the study protocol, in order to evaluate disease progression</measure>
    <time_frame>yearly up to 10 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)</condition>
  <arm_group>
    <arm_group_label>LGMD</arm_group_label>
    <description>Patients with GENETICALLY CONFIRMED limb girdle muscular dystrophy</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of GENETICALLY CONFIRMED LGMD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  You have a GENETICALLY CONFIRMED diagnosis of Limb Girdle Muscular Dystrophy

          -  You must be at least 6 years of age or older (if under 18 you will need Parental
             consent)

          -  You must be able to travel to the study site

          -  You must be able to provide a DNA/Gene testing report that confirms a diagnosis of
             LGMD

        Exclusion Criteria:

          -  You or your child do not have a diagnosis of LGMD

          -  Your child is under age 6

          -  You or your child are not able to travel to the study site
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Sparks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolinas Medical Center - Pediatrics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacqueline Sykes</last_name>
    <phone>704-333-3967</phone>
    <email>Jacqueline.Sykes@carolinashealthcare.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Carolinas Medical Center - Pediatrics</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Sykes</last_name>
      <phone>704-333-3967</phone>
      <email>jacqueline.sykes@carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Susan Sparks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amy Harper, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Bravver, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>January 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Carolinas Healthcare System</investigator_affiliation>
    <investigator_full_name>Susan Sparks</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>GENETICALLY CONFIRMED limb girdle muscular dystrophy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophies, Limb-Girdle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
